An observational analysis has found that the drugs may lower the risk of substance abuse and cognitive issues. But the findings need clinical testing.

A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.

Viking Therapeutics struggles with FDA approval and scaling up. Find out why VKTX stock’s path remains uncertain, despite its ...

About one in eight adults in the United States has tried or currently uses a GLP-1 medication, and a quarter of those users cite weight loss as their main goal.

Oprah Winfrey has been slammed for her controversial comments about 'thin people' while discussing her use of weight loss ...

THESE MEDICATIONS ARE MOSTLY KNOWN FOR TREATING DIABETES AND OBESITY.. BUT THE F-D-A HAS APPROVED THEM FOR PREVENTING HEART ...

The media queen also confessed that she was reluctant to take a GLP-1 drug because she felt it was “the easy way out.” That ...

When children with obesity undergo weight-loss treatment, the results have effects later in life, and the risk of serious ...

When it comes to medically assisted weight loss, there’s two main schools of thought: either weight loss drugs, like the ...

A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...

Weight-loss jabs could be linked to lower risk of several conditions including stroke and dementia - Researchers said ...

The market for GLP-1 drugs is projected to exceed $200 billion in annual sales by 2031, according to Morningstar Equity ...